Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy

Troy Wanandy, Yoshikazu Honda-Okubo, Noel W. Davies, Hayley E. Rose, Robert J. Heddle, Simon G.A. Brown, Richard J. Woodman, Nikolai Petrovsky, Michael D. Wiese

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds